Nachman PH - Search Results

1

Alternative therapies and future intervention for treatment of membranous nephropathy.

Kshirsagar AV, Nachman PH, Falk RJ. Kshirsagar AV, et al. Among authors: nachman ph. Semin Nephrol. 2003 Jul;23(4):362-72. doi: 10.1016/s0270-9295(03)00047-0. Semin Nephrol. 2003. PMID: 12923724

2

Shared idiotypy among patients with myeloperoxidase-anti-neutrophil cytoplasmic autoantibody associated glomerulonephritis and vasculitis.

Nachman PH, Reisner HM, Yang JJ, Jennette JC, Falk RJ. Nachman PH, et al. Lab Invest. 1996 Feb;74(2):519-27. Lab Invest. 1996. PMID: 8780169

3

Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.

Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ. Hogan SL, et al. Among authors: nachman ph. J Am Soc Nephrol. 1996 Jan;7(1):23-32. doi: 10.1681/ASN.V7123. J Am Soc Nephrol. 1996. PMID: 8808106

4

Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.

Nachman PH, Hogan SL, Jennette JC, Falk RJ. Nachman PH, et al. J Am Soc Nephrol. 1996 Jan;7(1):33-9. doi: 10.1681/ASN.V7133. J Am Soc Nephrol. 1996. PMID: 8808107 Clinical Trial.

5

Mycophenolate mofetil therapy in lupus nephritis: clinical observations.

Dooley MA, Cosio FG, Nachman PH, Falkenhain ME, Hogan SL, Falk RJ, Hebert LA. Dooley MA, et al. Among authors: nachman ph. J Am Soc Nephrol. 1999 Apr;10(4):833-9. doi: 10.1681/ASN.V104833. J Am Soc Nephrol. 1999. PMID: 10203368 Clinical Trial.

6

ANCA glomerulonephritis and vasculitis: a Chapel Hill perspective.

Falk RJ, Nachman PH, Hogan SL, Jennette JC. Falk RJ, et al. Among authors: nachman ph. Semin Nephrol. 2000 May;20(3):233-43. Semin Nephrol. 2000. PMID: 10855933 Review.

7

Silica exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis.

Hogan SL, Satterly KK, Dooley MA, Nachman PH, Jennette JC, Falk RJ. Hogan SL, et al. Among authors: nachman ph. J Am Soc Nephrol. 2001 Jan;12(1):134-142. doi: 10.1681/ASN.V121134. J Am Soc Nephrol. 2001. PMID: 11134259

8

Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplasmic autoantibody-associated glomerulonephritis.

Yang JJ, Pendergraft WF, Alcorta DA, Nachman PH, Hogan SL, Thomas RP, Sullivan P, Jennette JC, Falk RJ, Preston GA. Yang JJ, et al. Among authors: nachman ph. J Am Soc Nephrol. 2004 Aug;15(8):2103-14. doi: 10.1097/01.ASN.0000135058.46193.72. J Am Soc Nephrol. 2004. PMID: 15284296

9

A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis.

Joy MS, Hogan SL, Jennette JC, Falk RJ, Nachman PH. Joy MS, et al. Among authors: nachman ph. Nephrol Dial Transplant. 2005 Dec;20(12):2725-32. doi: 10.1093/ndt/gfi117. Epub 2005 Sep 27. Nephrol Dial Transplant. 2005. PMID: 16188901

10

Association between thyroid disease and its treatment with ANCA small-vessel vasculitis: a case-control study.

Lionaki S, Hogan SL, Falk RJ, Joy MS, Chin H, Jennette CE, Jennette JC, Nachman PH. Lionaki S, et al. Among authors: nachman ph. Nephrol Dial Transplant. 2007 Dec;22(12):3508-15. doi: 10.1093/ndt/gfm493. Epub 2007 Aug 8. Nephrol Dial Transplant. 2007. PMID: 17686815

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results